MedKoo Cat#: 591374 | Name: Prazitone

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Prazitone is a barbiturate derivative developed in the 1970s. Unlike most barbiturates, it has little or no sedative effects, instead acting as a non-sedating anxiolytic and antidepressant. Prazitone is discontinued.

Chemical Structure

Prazitone
CAS#2409-26-9

Theoretical Analysis

MedKoo Cat#: 591374

Name: Prazitone

CAS#: 2409-26-9

Chemical Formula: C16H19N3O3

Exact Mass: 301.1426

Molecular Weight: 301.35

Elemental Analysis: C, 63.77; H, 6.36; N, 13.94; O, 15.93

Price and Availability

This product was removed for the commercial reasons.
Related CAS #
No Data
Synonym
Prazitone; AGN 511; AGN-511; AGN511
IUPAC/Chemical Name
5-Phenyl-5-(2-piperidyl-methyl)barbituric acid
InChi Key
UGZAKKMLMJITLL-UHFFFAOYSA-N
InChi Code
InChI=1S/C16H19N3O3/c20-13-16(11-6-2-1-3-7-11,14(21)19-15(22)18-13)10-12-8-4-5-9-17-12/h1-3,6-7,12,17H,4-5,8-10H2,(H2,18,19,20,21,22)
SMILES Code
O=C(NC(C1(C2=CC=CC=C2)CC3NCCCC3)=O)NC1=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 301.35 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Lebar MD, Cary JW, Majumdar R, Carter-Wientjes CH, Mack BM, Wei Q, Uka V, De Saeger S, Diana Di Mavungu J. Identification and functional analysis of the aspergillic acid gene cluster in Aspergillus flavus. Fungal Genet Biol. 2018 Apr 16;116:14-23. doi: 10.1016/j.fgb.2018.04.009. [Epub ahead of print] PubMed PMID: 29674152. 2: Belfrage AK, Abdurakhmanov E, Åkerblom E, Brandt P, Alogheli H, Neyts J, Danielson UH, Sandström A. Pan-NS3 protease inhibitors of hepatitis C virus based on an R(3)-elongated pyrazinone scaffold. Eur J Med Chem. 2018 Mar 25;148:453-464. doi: 10.1016/j.ejmech.2018.02.032. Epub 2018 Feb 13. PubMed PMID: 29477077. 3: Đaković M, Soldin Ž, Kukovec BM, Kodrin I, Aakeröy CB, Baus N, Rinkovec T. Building inorganic supramolecular architectures using principles adopted from the organic solid state. IUCrJ. 2018 Jan 1;5(Pt 1):13-21. doi: 10.1107/S2052252517015494. eCollection 2018 Jan 1. PubMed PMID: 29354267; PubMed Central PMCID: PMC5755573. 4: Perkins JC, Wang X, Pike RD, Scheerer JR. Further Investigation of the Intermolecular Diels-Alder Cycloaddition for the Synthesis of Bicyclo[2.2.2]diazaoctane Alkaloids. J Org Chem. 2017 Dec 15;82(24):13656-13662. doi: 10.1021/acs.joc.7b02403. Epub 2017 Nov 27. PubMed PMID: 29172511. 5: Peng X, Wang Y, Zhu T, Zhu W. Pyrazinone derivatives from the coral-derived Aspergillus ochraceus LCJ11-102 under high iodide salt. Arch Pharm Res. 2018 Feb;41(2):184-191. doi: 10.1007/s12272-017-0928-8. Epub 2017 Jul 14. PubMed PMID: 28710560. 6: Campos PT, Rodrigues LV, Belladona AL, Bender CR, Bitencurt JS, Rosa FA, Back DF, Bonacorso HG, Zanatta N, Frizzo CP, Martins MA. Regiochemistry of cyclocondensation reactions in the synthesis of polyazaheterocycles. Beilstein J Org Chem. 2017 Feb 10;13:257-266. doi: 10.3762/bjoc.13.29. eCollection 2017. PubMed PMID: 28326135; PubMed Central PMCID: PMC5331339. 7: Hartz RA, Vrudhula VM, Ahuja VT, Grace JE, Lodge NJ, Bronson JJ, Macor JE. Synthesis and evaluation of prodrugs of corticotropin-releasing factor-1 (CRF(1)) receptor antagonist BMS-665053 leading to improved oral bioavailability. Bioorg Med Chem Lett. 2017 Mar 15;27(6):1360-1363. doi: 10.1016/j.bmcl.2017.02.015. Epub 2017 Feb 10. PubMed PMID: 28223020. 8: Inoue N, Nakano SI, Harada S, Hamada Y, Nemoto T. Synthetic Study of Dragmacidin E: Construction of the Core Structure Using Pd-Catalyzed Cascade Cyclization and Rh-Catalyzed Aminoacetoxylation. J Org Chem. 2017 Mar 3;82(5):2787-2793. doi: 10.1021/acs.joc.7b00083. Epub 2017 Feb 23. PubMed PMID: 28217992. 9: Shaala LA, Youssef DT, Badr JM, Harakeh SM. Bioactive 2(1H)-Pyrazinones and Diketopiperazine Alkaloids from a Tunicate-Derived Actinomycete Streptomyces sp. Molecules. 2016 Aug 24;21(9). pii: E1116. doi: 10.3390/molecules21091116. PubMed PMID: 27563872. 10: Park HB, Crawford JM. Pyrazinone protease inhibitor metabolites from Photorhabdus luminescens. J Antibiot (Tokyo). 2016 Aug;69(8):616-21. doi: 10.1038/ja.2016.79. Epub 2016 Jun 29. PubMed PMID: 27353165; PubMed Central PMCID: PMC5003743. 11: Belfrage AK, Abdurakhmanov E, Kerblom E, Brandt P, Oshalim A, Gising J, Skogh A, Neyts J, Danielson UH, Sandström A. Discovery of pyrazinone based compounds that potently inhibit the drug-resistant enzyme variant R155K of the hepatitis C virus NS3 protease. Bioorg Med Chem. 2016 Jun 15;24(12):2603-20. doi: 10.1016/j.bmc.2016.03.066. Epub 2016 Apr 8. PubMed PMID: 27160057. 12: Ahuja VT, Hartz RA, Molski TF, Mattson GK, Lentz KA, Grace JE Jr, Lodge NJ, Bronson JJ, Macor JE. Synthesis and evaluation of carbamate and aryl ether substituted pyrazinones as corticotropin releasing factor-1 (CRF₁) receptor antagonists. Bioorg Med Chem Lett. 2016 May 1;26(9):2184-7. doi: 10.1016/j.bmcl.2016.03.067. Epub 2016 Mar 17. PubMed PMID: 27020524. 13: Robins JG, Kim KJ, Chinn AJ, Woo JS, Scheerer JR. Intermolecular Diels-Alder Cycloaddition for the Construction of Bicyclo[2.2.2]diazaoctane Structures: Formal Synthesis of Brevianamide B and Premalbrancheamide. J Org Chem. 2016 Mar 18;81(6):2293-301. doi: 10.1021/acs.joc.5b02744. Epub 2016 Feb 26. PubMed PMID: 26916112; PubMed Central PMCID: PMC4993160. 14: Maha A, Rukachaisirikul V, Saithong S, Phongpaichit S, Poonsuwan W, Sakayaroj J, Saparpakorn P, Hannongbua S. Terezine derivatives from the fungus Phoma herbarum PSU-H256. Phytochemistry. 2016 Feb;122:223-229. doi: 10.1016/j.phytochem.2015.11.009. Epub 2015 Nov 27. PubMed PMID: 26626161. 15: Leibowitz MK, Winter ES, Scheerer JR. 3,4- and 3,5-Disubstituted 2-Pyridones Using an Intermolecular Cycloaddition / Cycloreversion Strategy: Toward the Synthesis of Aristopyridinone A. Tetrahedron Lett. 2015 Oct 28;56(44):6069-6072. PubMed PMID: 26543258; PubMed Central PMCID: PMC4629259. 16: Allmann TC, Moldovan RP, Jones PG, Lindel T. Synthesis of Hydroxypyrrolone Carboxamides Employing Selectfluor. Chemistry. 2016 Jan 4;22(1):111-5. doi: 10.1002/chem.201503695. Epub 2015 Nov 27. PubMed PMID: 26510486. 17: Kaddi CD, Bennett RV, Paine MR, Banks MD, Weber AL, Fernández FM, Wang MD. DetectTLC: Automated Reaction Mixture Screening Utilizing Quantitative Mass Spectrometry Image Features. J Am Soc Mass Spectrom. 2016 Feb;27(2):359-65. doi: 10.1007/s13361-015-1293-9. Epub 2015 Oct 27. PubMed PMID: 26508443; PubMed Central PMCID: PMC5003040. 18: Azab ME, Rizk SA, Amr Ael-G. Synthesis of Some Novel Heterocyclic and Schiff Base Derivatives as Antimicrobial Agents. Molecules. 2015 Oct 7;20(10):18201-18. doi: 10.3390/molecules201018201. PubMed PMID: 26457697. 19: Taggi AE, Stevenson TM, Bereznak JF, Sharpe PL, Gutteridge S, Forman R, Bisaha JJ, Cordova D, Crompton M, Geist L, Kovacs P, Marshall E, Sheth R, Stavis C, Tseng CP. Tubulin modulating antifungal and antiproliferative pyrazinone derivatives. Bioorg Med Chem. 2016 Feb 1;24(3):435-43. doi: 10.1016/j.bmc.2015.08.038. Epub 2015 Aug 28. PubMed PMID: 26386818. 20: Gu C, Lewis RJ, Wells AS, Svensson PH, Hosagrahara VP, Johnsson E, Hallström G. Lipid Peroxide-Mediated Oxidative Rearrangement of the Pyrazinone Carboxamide Core of Neutrophil Elastase Inhibitor AZD9819 in Blood Plasma Samples. Drug Metab Dispos. 2015 Oct;43(10):1441-9. doi: 10.1124/dmd.115.065136. Epub 2015 Jul 22. PubMed PMID: 26203069.